" class="no-js "lang="en-US"> Tom Hudson - Medtech Alert
Tuesday, April 16, 2024

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Tom Hudson

Tom Hudson

About Tom Hudson

Related Story

Industry News

 AbbVie and Gedeon Richter Announce Collaboration in Neuropsychiatric Diseases | Pharmtech Focus

AbbVie and Gedeon Richter Announce Collaboration in Neuropsychiatric Diseases

March 11 2022

AbbVie (NYSE: ABBV) and Gedeon Richter Plc. (‘Richter’) today announced a new co-development and license […]

Diseases

 AbbVie and REGENXBIO Announce Eye Care Collaboration | Pharmtech Focus

AbbVie and REGENXBIO Announce Eye Care Collaboration

September 14 2021

AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) today announced a partnership to develop and […]

Diseases

 AbbVie and Calico Announce Second Extension of Collaboration Focused on Aging and Age-Related Diseases | Pharmtech Focus

AbbVie and Calico Announce Second Extension of Collaboration Focused on Aging and Age-Related Diseases

July 27 2021

AbbVie (NYSE: ABBV) and Calico Life Sciences today announced an extension of their leading-edge collaboration […]